Biotech Support Group presented 2 posters at the ASMS 2021 Conference on Mass Spectrometry & Allied Topics
Biotech Support Group and joint collaborators presented two posters at the ASMS 2021 Conference, in Philadelphia PA, Oct 31 – Nov. 4, 2021.

News Release


Biotech Support Group presented 2 posters at the ASMS 2021 Conference on Mass Spectrometry & Allied Topics


MONMOUTH JUNCTION, NJ , December 1, 2021 -- Biotech Support Group and joint collaborators presented two posters at the ASMS 2021 Conference, in Philadelphia PA, Oct 31 – Nov. 4, 2021 . The posters were:


A Preliminary Investigation Using Targeted LC-MS Proteomic Methods Demonstrates Unique Serum Profiles of Hospitalized SARS-CoV-2 Patients

Douglas D Fraser 1; Haiyan Zheng 2; Swapan Roy 3; Matt Kuruc 3; Amenah Soherwardy 2; Devjit Roy 4; Sowmya Avadhani 3

1Lawson Research Institute, London, Ontario; 2Rutgers University Proteomics Center, Piscataway, New Jersey; 3Biotech Support Group LLC, Monmouth Junction, NJ; 4Nathan Littauer Hospital, Gloversville, New York Corresponding Author : mkuruc@biotechsupportgroup.com

Click image to download

Brief description: For serum samples, targeted LC-MS is challenging, mainly due to the presence of highly abundant proteins. So it becomes critical to pair target peptides to sample depletion methods to best establish differentiated profiles between samples. In this preliminary investigation, we use unique methods described here to characterize the functionality of the innate immune response in hospitalized Covid-19 patients, more precisely than current methods.  

High-throughput, Automated INTip™ SPE Combined with AlbuSorb™ Products for Efficient Albumin and Albumin/IgG Depletion

Matthew Fitts 1; William E. Kemnitzer 1; Paul Meeh 1; Matt Kuruc 2; Swapan Roy 2; Sowmya Avadhani 2

1DPX Technologies, Columbia, SC; 2Biotech Support Group LLC, Monmouth Junction, NJ Corresponding Author: mkuruc@biotechsupportgroup.com

Click image to download

Brief description: We report here new methods to incorporate beads for depletion of Albumin, IgG and Hemoglobin, into pipette tips known as XTRaction tips or XTR tips. The XTR tip format improves ease of use and scalability to process multiple samples in parallel, utilizing 96-well plates and automated liquid handlers. The incorporated BSG beads are consumable, and not derived from immuno-affinity.

“These two posters highlight the value of collaborative partners jointly working to commercialize new methods and biomarkers using novel proteomic sample prep products. The first demonstrates how we can adapt LC-MS to study the functionality of a most important regulating family of proteins - the Serpins, as they serve as central control within the innate immune response. The second demonstrates our commitment to high-throughput and automation for clinical proteomics. It is very exciting to share these developments with a dedicated group at the forefront of mass spectrometry research”, states Dr. Swapan Roy, Ph.D., President and Founder of Biotech Support Group.  


For more information on BSG & Lawson Health Research Institute Collaborative Research Agreement, see our joint press release:

https://www.biotechsupportgroup.com/Articles.asp?ID=612


For more information on INTip™ SPE and BSG products, see our joint press release: https://www.biotechsupportgroup.com/Articles.asp?ID=615


For more information on the BSG complete line of Albumin & IgG Removal products , visit: https://www.biotechsupportgroup.com/Albumin-Removal-s/307.htm


For more information on the BSG complete line of Hemoglobin Removal products, visit:

https://www.biotechsupportgroup.com/Hemoglobin-Removal-s/312.htm


About Biotech Support Group LLC

Converging with cultural and technological disruptions forthcoming in healthcare, Biotech Support Group develops methods for cost effective and efficient sample prep essential for these expanding markets. Following a tiered business strategy, the company continues its growth in the consumable research products area supporting the rapidly expanding installation of LC-MS instrument and computational infrastructure. For this market, key products include: AlbuVoid™ and AlbuSorb™ for albumin depletion, Cleanascite™ for lipid adsorption, and HemogloBind™ and HemoVoid™ for hemoglobin removal. From these innovations, the company has acquired knowledgebase and biomarker intellectual property assets that support discoveries of protein markers from blood, with special emphasis on early detection and personalized medical decisions for cancer patients. For more information, go to https://www.biotechsupportgroup.com

For Business Development, contact: Matthew Kuruc 732-274-2866 mkuruc@biotechsupportgroup.com